Iloprost Therapy in Patients With Critical Limb Ischemia

Iloprost Therapy in Patients With Critical Limb Ischemia: Evaluation of Efficacy and Safety

Monitoring efficacy and safety aspects of iv. iloprost therapy of patients with critical limb ischemia by recording clinical parameters.

Inclusion Criteria:

• Patients who fulfill the internationally defined criteria of critical limb ischemia;
• Patients who are not eligible for vascular surgery or angioplasty interventions and
• Patients who are treated with iloprost infusion.
• The treating physician has decided iloprost treatment before study enrollment.

Exclusion Criteria:

• Exclusion criteria are in accordance with the Summary of Product Characteristics of Ilomedin.